What's Happening in Health: RNA treatment for brain cancer
UC research examines use of microbubbles, RNA for targeted brain tumor treatment
UC scientists are conducting research that could bring hope to those diagnosed with brain cancer.
Daniel Pomeranz Krummel, PhD, research associate professor at UC and author on a new study, was a guest on Local 12's What's Happening in Health, discussing a new RNA treatment being studied for brain tumors.
"We're developing a novel therapeutic approach that will help us treat adult and pediatric brain tumors," he says.
Watch the full interview (Note: Interview starts at around the 5:55 minute mark).
Soma Sengupta, MD, PhD, associate director of the UC Gardner Neuroscience Institute’s Brain Tumor Center, was also involved in this research and was interviewed by WCPO, Channel 9.
Read more about the study on UC News.
Featured photo of a brain courtesy of Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up to date on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
College student’s guide to pursuing intellectual property
May 7, 2025
UC students turn to the school’s Technology Transfer office to discover if their ideas or work can be considered intellectual property, if it should be protected and, if so, what options exist for doing so.
1819 startup flies high after national pitch
May 7, 2025
Airtrek Robotics, an 1819-based startup revolutionizing aviation safety, is soaring due to the positive publicity and valuable insights it gained during South by Southwest’s pitch competition.
UC researcher launches app to connect patients to lifesaving...
May 7, 2025
A cardiologist and researcher at UC’s College of Medicine joined the Venture Lab at the 1819 Innovation Hub to launch High Enroll, an app that links clinical trials with willing participants.